Federated Hermes’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $72.6M | Sell |
1,123,266
-451,355
| -29% | -$31.8M | 0.12% | 199 |
|
|
2025
Q4 | $106M | Buy |
1,574,621
+123,917
| +9% | +$8.34M | 0.18% | 138 |
|
|
2025
Q3 | $106M | Buy |
1,450,704
+1,082,638
| +294% | +$71.9M | 0.19% | 137 |
|
|
2025
Q2 | $19.1M | Buy |
368,066
+8,529
| +2% | +$485K | 0.04% | 438 |
|
|
2025
Q1 | $22.9M | Sell |
359,537
-29,856
| -8% | -$1.73M | 0.05% | 374 |
|
|
2024
Q4 | $18.6M | Sell |
389,393
-322,415
| -45% | -$16.5M | 0.04% | 425 |
|
|
2024
Q3 | $40.7M | Buy |
711,808
+15,677
| +2% | +$899K | 0.09% | 271 |
|
|
2024
Q2 | $36.4M | Buy |
696,131
+191,030
| +38% | +$8.38M | 0.09% | 275 |
|
|
2024
Q1 | $20.5M | Buy |
505,101
+45,732
| +10% | +$1.71M | 0.05% | 408 |
|
|
2023
Q4 | $17M | Buy |
459,369
+292,926
| +176% | +$11M | 0.04% | 425 |
|
|
2023
Q3 | $6.36M | Buy |
166,443
+113,760
| +216% | +$4.66M | 0.02% | 638 |
|
|
2023
Q2 | $1.9M | Buy |
52,683
+9,416
| +22% | +$321K | ﹤0.01% | 969 |
|
|
2023
Q1 | $1.65M | Sell |
43,267
-21,909
| -34% | -$1.03M | ﹤0.01% | 1017 |
|
|
2022
Q4 | $3.71M | Sell |
65,176
-8,665
| -12% | -$444K | 0.01% | 742 |
|
|
2022
Q3 | $2.92M | Sell |
73,841
-9,706
| -12% | -$429K | 0.01% | 802 |
|
|
2022
Q2 | $3.68M | Sell |
83,547
-2,614
| -3% | -$113K | 0.01% | 766 |
|
|
2022
Q1 | $3.44M | Sell |
86,161
-121,862
| -59% | -$4.34M | 0.01% | 872 |
|
|
2021
Q4 | $8.36M | Sell |
208,023
-113,693
| -35% | -$4.24M | 0.02% | 698 |
|
|
2021
Q3 | $13.1M | Buy |
321,716
+88,438
| +38% | +$3.7M | 0.02% | 576 |
|
|
2021
Q2 | $10.6M | Sell |
233,278
-152,659
| -40% | -$6.76M | 0.02% | 635 |
|
|
2021
Q1 | $16.1M | Buy |
385,937
+140,064
| +57% | +$6.39M | 0.03% | 549 |
|
|
2020
Q4 | $10.5M | Sell |
245,873
-180,047
| -42% | -$6.47M | 0.02% | 633 |
|
|
2020
Q3 | $11.2M | Sell |
425,920
-3,346
| -0.8% | -$93.2K | 0.03% | 544 |
|
|
2020
Q2 | $11.5M | Buy |
429,266
+369,599
| +619% | +$8.34M | 0.03% | 506 |
|
|
2020
Q1 | $1.07M | Sell |
59,667
-255,540
| -81% | -$4.85M | ﹤0.01% | 1115 |
|
|
2019
Q4 | $5.59M | Sell |
315,207
-217,310
| -41% | -$3.76M | 0.01% | 740 |
|
|
2019
Q3 | $8.26M | Sell |
532,517
-289,266
| -35% | -$4.76M | 0.02% | 626 |
|
|
2019
Q2 | $14.1M | Sell |
821,783
-10,460
| -1% | -$169K | 0.03% | 463 |
|
|
2019
Q1 | $13.4M | Buy |
832,243
+209,033
| +34% | +$3.39M | 0.03% | 461 |
|
|
2018
Q4 | $9.12M | Buy |
623,210
+454,383
| +269% | +$7.25M | 0.02% | 528 |
|
|
2018
Q3 | $3.07M | Buy |
168,827
+63,015
| +60% | +$1.1M | 0.01% | 948 |
|
|
2018
Q2 | $1.78M | Sell |
105,812
-72,318
| -41% | -$1.37M | 0.01% | 1064 |
|
|
2018
Q1 | $3.49M | Buy |
178,130
+87,709
| +97% | +$1.7M | 0.01% | 752 |
|
|
2017
Q4 | $1.83M | Buy |
90,421
+35,558
| +65% | +$654K | 0.01% | 971 |
|
|
2017
Q3 | $953K | Sell |
54,863
-10,650
| -16% | -$144K | ﹤0.01% | 1215 |
|
|
2017
Q2 | $840K | Buy |
65,513
+17,685
| +37% | +$236K | ﹤0.01% | 1268 |
|
|
2017
Q1 | $620K | Buy |
47,828
+47,676
| +31,366% | +$603K | ﹤0.01% | 1286 |
|
|
2016
Q4 | $2K | Sell |
152
-1,852
| -92% | -$20.3K | ﹤0.01% | 2015 |
|
|
2016
Q3 | $24K | Sell |
2,004
-290
| -13% | -$2.96K | ﹤0.01% | 1734 |
|
|
2016
Q2 | $20K | Hold |
2,294
| – | – | ﹤0.01% | 1749 |
|
|
2016
Q1 | $22K | Sell |
2,294
-2,037
| -47% | -$19.2K | ﹤0.01% | 1726 |
|
|
2015
Q4 | $75K | Buy |
4,331
+4,200
| +3,206% | +$66.9K | ﹤0.01% | 1606 |
|
|
2015
Q3 | $2K | Sell |
131
-587
| -82% | -$11.8K | ﹤0.01% | 1859 |
|
|
2015
Q2 | $16K | Buy |
+718
| New | +$12.6K | ﹤0.01% | 1695 |
|
Other funds holding HALO
VCM
VPM
Federated Hermes's HALO Position: Q1 2026 in Review
Federated Hermes reduced its Halozyme (HALO) stake by 29% in Q1 2026, selling an estimated $31.8M and leaving 1,123,266 shares worth $72.6M. The position accounts for 0.12% of the portfolio, ranked #199.
Federated Hermes first reported a position in HALO in Q2 2015 and has held it in 44 quarters since. The position peaked at $106M in Q3 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.
- Federated Hermes held 1,123,266 shares of Halozyme worth $72.6M as of Q1 2026.
- Federated Hermes sold 451,355 Halozyme shares in Q1 2026, an estimated $31.8M.
- Halozyme made up 0.12% of Federated Hermes's portfolio in Q1 2026, its #199 holding.
- Federated Hermes first reported a position in Halozyme in Q2 2015 and has held it in 44 quarters since.
- Federated Hermes's Halozyme position peaked at $106M in Q3 2025.
- 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.
Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.